- Home
- TXG vs ETV Comparison
TXG vs ETV Comparison
Compare TXG & ETV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- ETV
- Stock Information
- Founded
- TXG 2012
- ETV 2005
- Country
- TXG United States
- ETV United States
- Employees
- TXG N/A
- ETV N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- ETV Investment Managers
- Sector
- TXG Industrials
- ETV Finance
- Exchange
- TXG Nasdaq
- ETV Nasdaq
- Market Cap
- TXG 1.6B
- ETV 1.7B
- IPO Year
- TXG 2019
- ETV N/A
- Fundamental
- Price
- TXG $13.32
- ETV $14.21
- Analyst Decision
- TXG Buy
- ETV
- Analyst Count
- TXG 12
- ETV 0
- Target Price
- TXG $13.54
- ETV N/A
- AVG Volume (30 Days)
- TXG 2.8M
- ETV 252.5K
- Earning Date
- TXG 11-06-2025
- ETV 01-01-0001
- Dividend Yield
- TXG N/A
- ETV 8.75%
- EPS Growth
- TXG N/A
- ETV N/A
- EPS
- TXG N/A
- ETV N/A
- Revenue
- TXG $644,466,000.00
- ETV N/A
- Revenue This Year
- TXG $2.11
- ETV N/A
- Revenue Next Year
- TXG N/A
- ETV N/A
- P/E Ratio
- TXG N/A
- ETV N/A
- Revenue Growth
- TXG 2.02
- ETV N/A
- 52 Week Low
- TXG $6.78
- ETV $11.05
- 52 Week High
- TXG $18.21
- ETV $13.50
- Technical
- Relative Strength Index (RSI)
- TXG 57.51
- ETV 52.61
- Support Level
- TXG $12.08
- ETV $14.12
- Resistance Level
- TXG $13.45
- ETV $14.28
- Average True Range (ATR)
- TXG 0.76
- ETV 0.14
- MACD
- TXG 0.18
- ETV -0.01
- Stochastic Oscillator
- TXG 95.82
- ETV 42.45
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About ETV Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.